23andMe To Be Sold in Bankruptcy: What It Means for Your DNA Data

Biotech giant Regeneron announced Monday that it would acquire DNA testing company 23andMe for $256 million following a bankruptcy auction. The deal includes access to 23andMe's massive personal and genetic data trove from more than 15 million customers.

Regeneron, whose experimental antibody cocktail was used on President Donald Trump during his COVID-19 illness, says it will use the data to accelerate drug development.

Newsweek contacted Regeneron via email for further comment on the acquisition...